Literature DB >> 28095066

Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.

Asmaa Kamal1, Rania Kamal Darwish1, Samar Saad1, Mohamed Salama2, Tarek S El-Baradie2, Heba G M Mahmoud2, Yasmine Elshiwy1.   

Abstract

We investigated the association of the Osteopontin (OPN) (rs9138 and rs1126616) polymorphisms with colorectal cancer (CRC). One hundred CRC patients and 112 healthy individuals were subjected to OPN (rs9138 and rs1126616) genotyping and measurement of OPN protein plasma level. The C allele of OPN rs1126616 and the CC haplotype were significantly higher in CRC patient (p = 0.036, 0.003, respectively). In females, the C allele of OPN rs9318 (A/C) polymorphism was significantly associated with increased CRC risk (p = 0.036). The plasma OPN level >104.35 ng/mL was significantly associated with CRC. Our findings suggest a significant role played by OPN (rs9138 and rs1126616) in colorectal carcinogenesis.

Entities:  

Keywords:  Colorectal cancer; Gene polymorphism; OPN rs1126616; OPN rs9138; Osteopontin

Mesh:

Substances:

Year:  2017        PMID: 28095066     DOI: 10.1080/07357907.2016.1247454

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  Klotho (rs1207568 and rs564481) gene variants and colorectal cancer risk.

Authors:  Asmaa Kamal; Mohamed Salama; Amr Kamal; Ahmed Mohsen; Ibrahem Siam
Journal:  Turk J Gastroenterol       Date:  2020-07       Impact factor: 1.852

Review 2.  Colorectal Cancer and Bone Tissue: Fantastic Relations and Where to Find Them.

Authors:  Isabella Gigante; Valeria Tutino; Valentina De Nunzio; Maria Notarnicola
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

3.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

4.  Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.

Authors:  Jun Liu; Zheng Chen; Wenli Li
Journal:  J Oncol       Date:  2021-03-17       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.